RxDoctor Payments Data

Chad Schoenmann, NP

Family · Dalton, GANPI 1740578863

Payments from drug & device makers

$10,682in general payments, 2019–2025

Across 532 payments — averaging $20.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$2K
  • Novartis$2K
  • Lilly USA, LLC$1K
  • Sanofi$939
  • AbbVie$777
  • Regeneron Healthcare Solutions, Inc.$757
  • plus $3K from 21 others

What the payments were for

  • Consulting fees$1,06310%
  • Travel & lodging$1541%
  • Food & beverage$9,09785%
  • Education$3693%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,682 in reported general payments places this provider in the 95th percentile of 6,258 family providers in Georgia.

See all family providers in Georgia

Medicare billing

Part B allowed, 2024
$174,559
Medicare patients
659
Services billed
4,514

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cosentyx Sensoready (2 Pens)Secukinumab13$93,836
Dupixent SyringeDupilumab19$70,645
Dupixent PenDupilumab16$66,526
Ketoconazole248$4,620
Clobetasol Propionate65$3,129
Fluorouracil37$2,815
Metronidazole43$2,577
Triamcinolone Acetonide215$2,270
Doxycycline Hyclate109$1,524
Clindamycin Phosphate27$1,175
Mupirocin93$957
Fluocinolone Acetonide18$833
Fluocinonide20$743
Ciclopirox24$554
Permethrin11$505

Paid to pharmacies, not to this prescriber.

Other family in Dalton

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →